<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02087033</url>
  </required_header>
  <id_info>
    <org_study_id>RN-tvg-00313b</org_study_id>
    <nct_id>NCT02087033</nct_id>
  </id_info>
  <brief_title>Use of Ritmonutra in Subjects Affected by Supraventricular Ectopic Beats Without Structural Heart Disease</brief_title>
  <official_title>A Randomized, Double-blinded, Cross-over Study on the Use of Ritmonutra, a Nutraceutical Product Composed of Omega 3 Fatty Acids, Astaxanthin, Vitamin E and Hawthorn in Subjects Affected by Supraventricular Ectopic Beats Without Structural Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Donato</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Donato</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      it is a prospective, randomized, double-blinded, crossover study on the use of an association
      of omega 3 fatty acids, astaxanthin, vitamin E and hawthorn (ritmonutra) in subject affected
      by symptomatic supraventricular ectopic beats without structural heart disease.

      The study will evaluate the reduction of the number of supraventricular ectopic beats and
      symptoms related.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      24 subjects without structural heart disease with a minimum of 300 supraventricular ectopic
      beats in 24 hours will be enrolled in the two participating centers and randomized to the
      treatment or to the placebo for 4 weeks. At the end of the first treatment period, a 24 hours
      Holter ECG will be performed. After 1 week of wash-out therapy, subjects will be crossed over
      to the other treatment for 4 weeks. Another 24 hours Holter ECG will be performed at the end
      of the study. During the baseline visit and during each follow up visit, symptom score and
      quality of life questionnaires will be completed by the subjects.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy in reduction of supraventricular ectopic beats</measure>
    <time_frame>4 weeks of treatment</time_frame>
    <description>the primary outcome will evaluate the reduction of the number of supraventricular ectopic beats after 4 weeks of treatment using a 24 h holter recording.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy in reduction of symptoms related to supraventricular ectopic beats</measure>
    <time_frame>4 weeks</time_frame>
    <description>the secodary outcome will evaluate the reduction of symptoms related to supraventricular ectopic beats using a symptom score and a quality of life questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Arrhythmia</condition>
  <arm_group>
    <arm_group_label>ritmonutra and placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>ritmonutra 2 tablets/day by mouth for 4 weeks sugar pill manufatured to simulate ritmonutra: 2 tablets/day by mouth for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ritmonutra</intervention_name>
    <description>2 tablets a day by mouth for 4 weeks</description>
    <arm_group_label>ritmonutra and placebo</arm_group_label>
    <other_name>ritmonutra rottapharm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>sugar pill manufactured to simulated ritmonutra: 2 tablets a day for 4 weeks</description>
    <arm_group_label>ritmonutra and placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: 18 to 80 years

          -  symptomatic supraventricular ectopic beats (at least 300 in 24 hours recording)

          -  no structural heart disease evaluated with ecg, echocardiography, stress test and
             chest x-ray.

          -  no antiarrhythmic drug in use.

        Exclusion Criteria:

          -  acute systemic illness

          -  preexcitation

          -  3 or more consecutive ectopic beats

          -  vascular disease

          -  diabetes

          -  asthma

          -  soy allergy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>riccardo cappato, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico San Donato</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>riccardo cappato, MD</last_name>
    <phone>00390252774337</phone>
    <email>riccardo.cappato@grupposandonato.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico San Pietro</name>
      <address>
        <city>Ponte San Pietro</city>
        <state>Bergamo</state>
        <zip>24100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>flavio doni, MD</last_name>
      <phone>0039035604416</phone>
      <email>flavio.doni@fastwebnet.it</email>
    </contact>
    <investigator>
      <last_name>flavio doni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico San Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <state>Milan</state>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>riccardo cappato, MD</last_name>
      <phone>0252774337</phone>
      <email>riccardo.cappato@grupposandonato.it</email>
    </contact>
    <investigator>
      <last_name>Cristina Balla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2014</study_first_submitted>
  <study_first_submitted_qc>March 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <last_update_submitted>March 7, 2014</last_update_submitted>
  <last_update_submitted_qc>March 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Donato</investigator_affiliation>
    <investigator_full_name>Riccardo Cappato</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>supraventricular ectopic beats</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Cardiac Complexes, Premature</mesh_term>
    <mesh_term>Atrial Premature Complexes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

